Does Rallies show live market data for IRMD?

Rallies combines live market context with ticker research for IRMD, including charts, news, financials, analyst data, institutional holdings, politician trades, insider activity, and AI research where available.

IRMD (iRadimed Corporation) Stock Analysis

iRadimed Corporation (IRMD) is a publicly traded Healthcare sector company. As of May 21, 2026, IRMD trades at $90.40 with a market cap of $1.13B and a P/E ratio of 47.84. IRMD moved +1.82% today. Year to date, IRMD is -8.04%; over the trailing twelve months it is +69.64%. Its 52-week range spans $46.86 to $107.90. Analyst consensus is buy with an average price target of $116.00. Rallies surfaces IRMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the latest IRMD stock research?

iRadimed Corporation (IRMD) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. IRMD moved +1.82% today. Analyst consensus is buy.

IRMD Key Metrics

Key financial metrics for IRMD
Metric	Value
Price	$90.40
Market Cap	$1.13B
P/E Ratio	47.84
EPS	$1.86
Dividend Yield	0.20%
52-Week High	$107.90
52-Week Low	$46.86
Volume	0
Avg Volume	0
Revenue (TTM)	$86.28M
Net Income	$23.61M
Gross Margin	76.83%

Latest IRMD News

iRadimed Q1 Revenue Jumps 13% to $22M; 3,870 Pump ASPs Rise 20% — May 2, 2026
IRadimed Q1 Revenue Rises 13% to $22M, Launches Next-Gen 3870 Pump — May 1, 2026
IRadimed Q4 Revenue Rises 17% to $22.7M, Raises Guidance and Dividend — Feb 20, 2026
iRadimed Posts Record Q4 2025 Revenue, Plans Europe and Asia Expansion — Feb 10, 2026
IRadimed Sets 18th Straight Record Quarterly Revenue, Beats Profit Estimates — Feb 10, 2026

Recent IRMD Insider Trades

Susi Roger E. sold 653 (~$56.90K) on May 19, 2026.
Susi Roger E. sold 1.84K (~$162.27K) on May 19, 2026.
Susi Roger E. sold 6 (~$531.9) on May 19, 2026.

IRMD Analyst Consensus

1 analysts cover IRMD: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $116.00.

Common questions about IRMD

What can I research for IRMD on Rallies?: iRadimed Corporation (IRMD) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. IRMD moved +1.82% today. Analyst consensus is buy.
Does Rallies show live market data for IRMD?: Rallies combines live market context with ticker research for IRMD, including charts, news, financials, analyst data, institutional holdings, politician trades, insider activity, and AI research where available.